Report Code : CVMI24071658 | Published Date : July 16, 2024
The Dermatological Therapeutics Market is experiencing steady growth, driven by the rising prevalence of skin disorders, an increasing demand for biologics, and advancements in personalized dermatology treatments. The market, valued at USD XX billion in 2023, is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by 2031.
Key Market Insights
Dermatological therapeutics include prescription treatments for conditions like psoriasis, eczema, acne, and skin cancer. The increasing use of biologic drugs, AI-driven dermatology diagnostics, and advanced topical formulations is shaping the industry.
Growth Drivers
- Rising Global Burden of Chronic Skin Disorders – The increasing cases of psoriasis, atopic dermatitis, and acne are fueling the demand for treatment demand.
- Breakthroughs in Biologics & Immunomodulatory Dermatology Drugs – The development of monoclonal antibodies, JAK inhibitors, and topical immunotherapies is revolutionizing patient care.
- Growing Focus on AI-Powered Skin Diagnostics and Teledermatology – AI-based skin lesion detection and virtual dermatology consultations are improving diagnosis rates.
- Expanding Availability of Non-Steroidal and Targeted Therapies – Companies are introducing safer, long-term treatment alternatives for inflammatory skin conditions.
Regional Trends
- North America excels because of robust dermatology research, high biologic adoption rates, and the growth of teledermatology services.
- Europe is advancing with government backing for dermatological innovations and cutting-edge skin treatments guidelines.
- The Asia-Pacific region is experiencing rapid growth, fueled by heightened consumer awareness and improved access to dermatology treatments.
- Latin America and MEA are emerging markets that benefit from the growth of medical dermatology programs.
ClearView Market Insights Analysis;
The Dermatological Therapeutics Market is poised for steady growth, fueled by advancements in biologic therapies, AI-driven dermatology solutions, and a rising emphasis on skin health awareness. Companies investing in personalized dermatology, targeted biologics, and non-steroidal therapies are likely to lead this evolving sector.
Reasons To Buy
Scope
Key Players
- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- AbbVie Inc.
- LEO Pharma A/S
Global Dermatological Therapeutics Market Report
- 1. Global Dermatological Therapeutics Market Research Report
- 1.1 Study Objectives
- 1.2 Global Dermatological Therapeutics Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Dermatological Therapeutics Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Indication
- 2.1.2 By Product Type
- 2.1.3 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Indication, By Product Type, By Country
- 3.3. Opportunities – By Indication, By Product Type, By Country
- 3.4. Trends – By Indication, By Product Type, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Dermatological Therapeutics Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Acne Vulgaris
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Psoriasis
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Dermatitis
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Rosacea
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.5 Skin Cancer
- 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.6 Others
- 5.6.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.6.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.6.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.6.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Topical Drugs
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Systemic Drugs
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Biologics
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 North America
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Europe
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Asia-Pacific
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Latin America
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.5 Middle East & Africa
- 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.6 Global Dermatological Therapeutics Market - Opportunity Analysis Index, By Indication, By Product Type, and Region, 2024 - 2031
- 8.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 8.1.1 Acne Vulgaris
- 8.1.2 Psoriasis
- 8.1.3 Dermatitis
- 8.1.4 Rosacea
- 8.1.5 Skin Cancer
- 8.1.6 Others
- 8.2.1 Topical Drugs
- 8.2.2 Systemic Drugs
- 8.2.3 Biologics
- 8.3.1 United States
- 8.3.2 Canada
8.5 Regional Trends Analysis
8.6 North America Global Dermatological Therapeutics Market Research Report - Company Profiles- 8.6.1 Company 1 (United States)
- 8.6.2 Company 2 (Canada)
- 8.6.3 Company 3 (Canada)
- 9.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Acne Vulgaris
- 9.1.2 Psoriasis
- 9.1.3 Dermatitis
- 9.1.4 Rosacea
- 9.1.5 Skin Cancer
- 9.1.6 Others
- 9.2.1 Topical Drugs
- 9.2.2 Systemic Drugs
- 9.2.3 Biologics
- 9.3.1 Germany
- 9.3.2 United Kingdom
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.3.7 Netherlands
- 9.3.8 Poland
- 9.3.9 Rest of Europe
9.5 Regional Trends Analysis
9.6 Europe Global Dermatological Therapeutics Market Research Report - Company Profiles- 9.6.1 Company 1 (Germany)
- 9.6.2 Company 2 (United Kingdom)
- 9.6.3 Company 3 (United Kingdom)
- 10.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Acne Vulgaris
- 10.1.2 Psoriasis
- 10.1.3 Dermatitis
- 10.1.4 Rosacea
- 10.1.5 Skin Cancer
- 10.1.6 Others
- 10.2.1 Topical Drugs
- 10.2.2 Systemic Drugs
- 10.2.3 Biologics
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia & NZ
- 10.3.6 ASEAN
- 10.3.7 Rest of Asia-Pacific
10.5 Regional Trends Analysis
10.6 Asia-Pacific Global Dermatological Therapeutics Market Research Report - Company Profiles- 10.6.1 Company 1 (China)
- 10.6.2 Company 2 (Japan)
- 10.6.3 Company 3 (Japan)
- 11.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Acne Vulgaris
- 11.1.2 Psoriasis
- 11.1.3 Dermatitis
- 11.1.4 Rosacea
- 11.1.5 Skin Cancer
- 11.1.6 Others
- 11.2.1 Topical Drugs
- 11.2.2 Systemic Drugs
- 11.2.3 Biologics
- 11.3.1 Brazil
- 11.3.2 Mexico
- 11.3.3 Argentina
- 11.3.4 Peru
- 11.3.5 Colombia
- 11.3.6 Rest of Latin America
11.5 Regional Trends Analysis
11.6 Latin America Global Dermatological Therapeutics Market Research Report - Company Profiles- 11.6.1 Company 1 (Brazil)
- 11.6.2 Company 2 (Mexico)
- 11.6.3 Company 3 (Mexico)
- 12.1 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Acne Vulgaris
- 12.1.2 Psoriasis
- 12.1.3 Dermatitis
- 12.1.4 Rosacea
- 12.1.5 Skin Cancer
- 12.1.6 Others
- 12.2.1 Topical Drugs
- 12.2.2 Systemic Drugs
- 12.2.3 Biologics
- 12.3.1 Saudi Arabia
- 12.3.2 UAE
- 12.3.3 South Africa
- 12.3.4 Egypt
- 12.3.5 Israel
- 12.3.6 Rest of Middle East and Africa
12.5 Regional Trends Analysis
12.6 Middle East & Africa Global Dermatological Therapeutics Market Research Report - Company Profiles- 12.6.1 Company 1 (Saudi Arabia)
- 12.6.2 Company 2 (UAE)
- 12.6.3 Company 3 (UAE)
- 13.1 Strategic Dashboard of Top Market Players
13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 13.2.1 Johnson & Johnson
- 13.2.2 Pfizer Inc.
- 13.2.3 Novartis AG
- 13.2.4 AbbVie Inc.
- 13.2.5 LEO Pharma A/S
15. Principal Presumptions and Acronyms